Melanoma

Merck advancing breast cancer drug to mid-stage

Drugmaker Merck & Co. said Wednesday that it will advance a new cancer drug into bigger patient tests, after promising findings in an early study against a very aggressive, common type of breast cancer.

Dec 10, 2014
popularity not rated yet | comments 0

Blue-eyed people may face higher melanoma risk

(HealthDay)—New research suggests that genes tied to blue eyes and red hair could put people at higher risk for moles or freckling in childhood, which are often precursors to the deadly skin cancer melanoma ...

Nov 19, 2014
popularity 5 / 5 (1) | comments 0

Next-gen melanoma drug, TAK-733, excels in lab tests

A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and tr ...

Nov 11, 2014
popularity 4.3 / 5 (4) | comments 0

Latest Spotlight News

Protein may be key to cancer's deadly resurgences

Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently ...